---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-008446"
form_type: "8-K"
ticker: "PTCT"
cik: "0001070081"
company_name: "PTC THERAPEUTICS, INC."
filed_at: "2024-05-20T23:59:59+00:00"
generated_at: "2026-06-01T12:13:47.405910+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# EC rejects CHMP negative opinion on Translarna; returns for re-evaluation; 2024 guidance paused

## Summary
- EC decided not to adopt CHMP's negative opinion for Translarna annual renewal; returns to CHMP for re-evaluation.
- Translarna remains authorized and available in Europe; EC asks CHMP to consider real-world evidence.
- PTC pauses 2024 total revenue guidance due to uncertainty from continued Translarna authorization upside.

## SEC filing metadata
- accession: 0001558370-24-008446
- form_type: 8-K
- ticker: PTCT
- cik: 0001070081
- company_name: PTC THERAPEUTICS, INC.
- filed_at: 2024-05-20T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1070081/000155837024008446/0001558370-24-008446-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1070081/000155837024008446/tmb-20240520x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-008446
- JSON: https://secwatch.observer/filing/0001558370-24-008446.json
- Plain text: https://secwatch.observer/filing/0001558370-24-008446.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.